A four-week , randomized , single-blind trial was performed in 58 patients with active , histologically confirmed ulcerative proctitis ( < or = 15 cm ) to evaluate the efficacy and safety of oral 800-mg mesalazine tablets taken three times per day ( n = 29 ) compared with 400 mg of mesalazine suppositories administered three times per day ( n = 29 ) .
